Top compounds associated with response to LEUTX


Feature Type Standardized
Nominal ANOVA
mRNA VU0155056 CTRPv2 pan-cancer AAC 0.056 0.1
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC 0.051 0.1
mRNA BRD-K96970199 CTRPv2 pan-cancer AAC 0.11 0.1
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.052 0.1
mRNA GSK4112 CTRPv2 pan-cancer AAC 0.054 0.1
mRNA JW-480 CTRPv2 pan-cancer AAC 0.055 0.1
mRNA MS-275 GDSC1000 pan-cancer AAC -0.074 0.1
mRNA FK866 CTRPv2 pan-cancer AAC -0.054 0.1
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.045 0.1
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.052 0.1
Download CSV